Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000929638-21-000667
Filing Date
2021-05-07
Accepted
2021-05-07 16:01:33
Documents
2
Group Members
BIHUA CHENCORMORANT ASSET MANAGEMENT, LPCORMORANT GLOBAL HEALTHCARE GP, LLCCORMORANT PRIVATE HEALTHCARE FUND II, LPCORMORANT PRIVATE HEALTHCARE FUND III, LPCORMORANT PRIVATE HEALTHCARE GP II, LLCCORMORANT PRIVATE HEALTHCARE GP III, LLC

Document Format Files

Seq Description Document Type Size
1 schedule13g.htm SC 13G 131127
2 exhibit99-1.htm EX-99.1 6010
  Complete submission text file 0000929638-21-000667.txt   139018
Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 617-848-3429
Cormorant Global Healthcare Master Fund, LP (Filed by) CIK: 0001618442 (see all company filings)

EIN.: 981101801 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 8000 JARVIS AVENUE SUITE 204 NEWARK CA 94560
Business Address 8000 JARVIS AVENUE SUITE 204 NEWARK CA 94560 (510) 953-5559
Rain Therapeutics Inc. (Subject) CIK: 0001724979 (see all company filings)

EIN.: 821130967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92501 | Film No.: 21902477
SIC: 2834 Pharmaceutical Preparations